Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02414867 · ClinicalTrials.gov registry record
Total Energy Expenditure and Fat Oxidation in 2 Year Old Children
A clinical trial, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 16
- Enrollment target
NCT02414867: Completed study, sponsored by Arkansas Children's Hospital Research Institute.
NCT02414867 is a clinical trial that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02414867 has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of the study is to determine energy expenditure and fat oxidation in 2 year old children.
Primary Outcome
Doubly labeled water is administered to 2 year old children and urine is collected at different time points.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-12 |
What the finished NCT02414867 record still lists
NCT02414867 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02414867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02414867 about?
NCT02414867 is a clinical study titled "Total Energy Expenditure and Fat Oxidation in 2 Year Old Children". The purpose of the study is to determine energy expenditure and fat oxidation in 2 year old children.
What is the current status of trial NCT02414867?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2015-02. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02414867?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia